Skip to main content

Table 1 Demographics at the beginning of the phase I studies of participants who were enrolled in the LTFU study

From: Observational long-term follow-up study of rapid food oral immunotherapy with omalizumab

Characteristics

LTFU participants

Number of ITT participants

34

Sex, male (n), female (n)

M (23), F (11)

Age at beginning of original phase I trial in years, median (range)

8.7 (4.6–16.9)

With other atopic conditions

 Atopic dermatitis (%)

57%

 Atopic rhinitis (%)

73%

 Asthma (%)

63%

With number food(s) in OIT

 1 food in OIT, n (%)

6 (17.6%)

 2 foods in OIT, n (%)

7 (20.6%)

 3 foods in OIT, n (%)

5 (14.7%)

 4 foods in OIT, (n (%)

9 (26.5%)

 5 foods in OIT, n (%)

7 (20.6%)

With food in OITa

 Almond, n (%)

6 (17.6%)

 Cashew, n (%)

18 (52.9%)

 Egg, n (%)

11 (32.4%)

 Hazelnut, n (%)

7 (20.6%)

 Milk, n (%)

10 (29.4%)

 Peanut, n (%)

26 (76.5%)

 Pecan, n (%)

8 (23.5%)

 Walnut, n (%)

10 (29.4%)

  1. OIT oral immunotherapy
  2. aOther foods with n = 1 not listed: e.g. Barely, Soy, Rye